x
- Home
- About Diabetes
- Services
- Diabetes Mellitus Modeling Solutions
- R&D Services for Diabetes Mellitus and Diabetic Complications
- By Drug Development Process
- About Us
- Careers
- Contact Us
Cat. No.: DCL-001183
| Product Information | |
|---|---|
| Organism | Human |
| Tissue | Human adipose tissue |
| Cell Type | Adipose-derived stem cells |
| Product Description | Human stromal vascular fraction (hSVF) is freshly isolated heterogeneous cell fraction derived from native adipose tissue or liposuction aspirates from normal donors, patients with Obesity (BMI>30) or Type 2 Diabetes . SVF contains mature cells (e.g., fibroblasts, smooth muscle, endothelial, blood cells), progenitor cells (e.g., preadipocytes and endothelial, vascular, and hematopoietic progenitors), and, most importantly, stem cells (e.g., mesenchymal and hematopoietic stem cells, pericytes, and supra-adventitial cells), which are also known as adipose tissue-derived stromal cells (ADSCs) . SVF has attracted substantial attention for its potential use in regenerative medicine in various fields, including internal medicine, potenzmittel, orthopedics, plastic and general surgery, and wound healing . provides SVF from human subcutaneous white fat tissue by enzymatic isolation and cryopreserved at P0, with ≥ 1.0 million cells/vial (Normal) or 0.5 million cells/vial (Diseased). These cells are negative for HIV-1, HBV, HCV, mycoplasma, bacteria, yeast, and fungi. |
| Gene Description | SVF from human adipose tissues (Type 2 Diabetes) |
| Format | Frozen |
| Growth Properties | Adherent |
| Shipping & Storage | |
|---|---|
| Shipping | Cryopreserved on dry ice. |
| Storage Instructions | 37 °C, 95% Air, 5% CO2. Store in vapor phase of liquid nitrogen. |
| Storage Buffer/Media | Adipose-Derived Stem Cell Attachment Medium Adipose-Derived Stem Cell Growth Medium |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.
